國家衛生研究院 NHRI:Item 3990099045/6309
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 916974      線上人數 : 1531
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/6309


    題名: Prodigiosin down-regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells
    作者: Hsieh, HY;Shieh, JJ;Chen, CJ;Pan, MY;Yang, SY;Lin, SC;Chang, JS;Lee, AY;Chang, CC
    貢獻者: National Institute of Cancer Research
    摘要: Background and purpose: High levels of SKP2 are a poor prognostic factor in multiple human cancers and mostly correlate with low p27(KIP1) levels. Prodigiosin is a bacterial tripyrrole pigment with strong proapoptotic activity. Induction of cell cycle blockade underlies one of prodigiosin's anticancer action with unclear mechanisms. The aim of this study was to explore the role of the SKP2-p27(KIP1) axis in prodigiosin's cytostatic effect on human lung adenocarcinoma cells. Experimental approach: Prodigiosin's effects on cell cycle progression and long-term cell proliferation of human lung adenocarcinoma cells were characterized by flow cytometry and colony formation assay, respectively. Real-time RT-PCR and promoter activity analyses were performed for assessing transcriptional control, while cycloheximide chase analysis for protein stability evaluation. Immunoblotting were employed for mechanistic study. Key results: Prodigiosin increased p27(KIP1) expression mainly by stabilizing p27(KIP1) through transcriptional repression of SKP2. Importantly, SKP2 overexpression or p27(KIP1) depletion restored colony formation capacity of prodigiosin-treated cells. Furthermore, prodigiosin induced AKT dephosphorylation, leading to AKT inhibition as revealed by decreased serine 9 phopshorylation of GSK-3beta. Constitutive AKT activation nearly abroagted prodigiosin-induced SKP2 repression. Additionally, prodigiosin down-regulated E2F1, previously reported to mediate PI3K/AKT-induced SKP2 transcription. However, E2F1 overexpression failed to restore SKP2 expression in prodigiosin-treated cells. Conclusions and implications: Transcriptional repression of SKP2 and the consequent accumulation of p27(KIP1) are indispensable for prodigiosin's antiproliferative action. Mechanistically, prodigiosin induces AKT inhibition to down-regulate SKP2 in GSK-3beta- and E2F1-independent manners. Our findings further implicate the potential for developing prodigiosin as a novel class of SKP2-targeting anticancer agent.
    日期: 2012-08
    關聯: British Journal of Pharmacology. 2012 Aug;166(7):2095-2108.
    Link to: http://dx.doi.org/10.1111/j.1476-5381.2012.01921.x
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0007-1188&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000306186700011
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84862215651
    顯示於類別:[李岳倫] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB22372491.pdf1391KbAdobe PDF664檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋